Back to Search
Start Over
The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine
- Source :
- Cells, Cells, Vol 10, Iss 2471, p 2471 (2021), Volume 10, Issue 9
- Publication Year :
- 2021
-
Abstract
- Mitochondrial processes may play a role in the pathophysiology of migraine. Serum levels of two biomarkers, Fibroblast-growth-factor 21 (FGF-21) and Growth-differentiation-factor 15 (GDF-15), are typically elevated in patients with mitochondrial disorders. The study investigated whether the presence of migraine may influence FGF-21 and GDF-15 serum levels considering vascular and metabolic disorders as possible confounders. A cross-sectional study in two headache centers was conducted analyzing GDF-15 and FGF-21 serum concentration in 230 patients with episodic and chronic migraine compared to a control group. Key clinical features of headache were evaluated, as well as health-related life quality, anxiety and depression using SF-12 and HADS-questionnaires. Elevated GDF-15 values were detected in the migraine group compared to the control group (506.65 ± 275.87 pg/mL vs. 403.34 ± 173.29 pg/mL, p &lt<br />0.001, Mann–Whitney U test). A strong correlation between increasing age and higher GDF-15 levels was identified (p &lt<br />0.001, 95%-CI elevation of GDF-15 per year 5.246–10.850 pg/mL, multiple linear regression). Mean age was different between the groups, and this represents a confounding factor of the measurements. FGF-21 levels did not differ between migraine patients and controls (p = 0.635, Mann–Whitney U test) but were significantly influenced by increasing BMI (p = 0.030, multiple linear regression). Neither biomarker showed correlation with headache frequency. Higher FGF-21 levels were associated with a higher mean intensity of headache attacks, reduced health-related life quality and anxiety. When confounding factors were considered, increased serum levels of FGF-21 and GDF-15 were not detected in migraine patients. However, the results show an age-dependence of GDF-15 in migraine patients, and this should be considered in future studies. Similar findings apply to the relationship between FGF-21 and BMI. Previous studies that did not adjust for these factors should be interpreted with caution.
- Subjects :
- Adult
Male
medicine.medical_specialty
Growth Differentiation Factor 15
Mitochondrial Diseases
Adolescent
QH301-705.5
Migraine Disorders
Gastroenterology
Severity of Illness Index
Article
Young Adult
Chronic Migraine
Internal medicine
Germany
mitochondrial disorder
medicine
Humans
migraine
Biology (General)
Depression (differential diagnoses)
Aged
FGF-21
business.industry
Confounding
General Medicine
Middle Aged
medicine.disease
Pathophysiology
GDF-15
Fibroblast Growth Factors
Cross-Sectional Studies
Migraine
Case-Control Studies
Chronic Disease
Mann–Whitney U test
Anxiety
Biomarker (medicine)
Female
medicine.symptom
business
headache
Biomarkers
Subjects
Details
- ISSN :
- 20734409
- Volume :
- 10
- Issue :
- 9
- Database :
- OpenAIRE
- Journal :
- Cells
- Accession number :
- edsair.doi.dedup.....130af681e1ab1a19c6782137dff9e3f3